Last reviewed · How we verify
Cortexone (desoxycortone)
Cortexone (generic name: desoxycortone) is a desoxycortone drug. It is currently in unknown development.
Cortexone works by binding to the mineralocorticoid receptor, mimicking the effects of naturally occurring corticosteroids.
Cortexone, also known as desoxycortone, is a small molecule that targets the mineralocorticoid receptor. It is a synthetic corticosteroid, but its exact commercial status and approved indications are unknown. As a desoxycortone, it is classified as a synthetic corticosteroid, but further information on its development, approval, and manufacturing is not available. Further research is needed to understand its pharmacokinetics and safety profile. Its exact mechanism of action and clinical applications are unclear.
At a glance
| Generic name | desoxycortone |
|---|---|
| Drug class | desoxycortone |
| Target | Corticosteroid-binding globulin, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2A |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Imagine your body has locks on the cells that control how much water and salt you have. The mineralocorticoid receptor is like a key that unlocks these locks, allowing the right amount of water and salt to enter the body. Cortexone is like a fake key that fits into these locks, telling the cells to behave in a certain way.
Approved indications
Common side effects
Drug interactions
- aripiprazole
- quetiapine
- risperidone
Key clinical trials
- Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome (PHASE4)
- Placebo Effects on Blood Pressure (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cortexone CI brief — competitive landscape report
- Cortexone updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Cortexone
What is Cortexone?
How does Cortexone work?
What is the generic name of Cortexone?
What drug class is Cortexone in?
What development phase is Cortexone in?
What does Cortexone target?
Related
- Drug class: All desoxycortone drugs
- Target: All drugs targeting Corticosteroid-binding globulin, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2A
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing